Case Studies

An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...

Recent Blog Posts

July 6, 2010 |

Partnership to Improve Patient Care (PIPC) chairman, Tony Coelho, recently delivered a speech on patient centered comparative effectiveness research (CER) in front of fifty specialty doctors from around the country, among others, at the Alliance for Specialty Medicine’s (ASM) “Capitol Hill Advocacy Conference.” The conference took place just a day before the specialty doctors met w

| Read More
June 24, 2010 |

Below: PIPC Chairman Tony Coelho's recent speech on patient centered CER. The speech was delivered on Tuesday, June 22, 2010 at the Alliance for Specialty Medicine's “Capitol Hill Advocacy Conference,” in Washington, D.C.

| Read More
June 10, 2010 |

A new Health Affairs article concludes, based on focus groups and interviews, that "consumers will revolt if evidence-based efforts are perceived as rationing or as a way to deny them needed treatment."

You don't need to look any further than public reaction to the U.S. Preventive Service Task Force's updated recommendations on mammography screening to see the proof of this.
 
How should policy-makers react? Should they conclude that consumers, and even more so, patients, cannot be relied on to make evidence-based decisions, and therefore these decisions need to be made for them? Or should they conclude that evidence-based models of medical care and health delivery need to be carefully constructed so they have the trust and support of patients and consumers?

| Read More

For Reporters

For journalists and other media professionals

More Information

Stay Connected

PIPC Comments on Federal Coordinating Council and Institute of Medicine CER Recommendations

WASHINGTON, July 8, 2009 – In response to the recent Federal Coordinating Council (FCC) and the Institute of Medicine (IOM) comparative effectiveness recommendations to Congress, Chairman of the Partnership to Improve Patient Care (PIPC), Tony Coelho, issued the following statement:

On behalf of the Partnership to Improve Patient Care (PIPC), I want to thank the Federal Coordinating Council (FCC) and the Institute of Medicine (IOM) for their hard work and thoughtful recommendations to Congress on the issue of comparative effectiveness research (CER).

Their advice to strengthen comparative effectiveness research by focusing on minority and underrepresented populations and ensuring that information is widely disseminated to doctors and patients is especially important to members of underserved communities like African-Americans, Latinos, Asian-Americans, and the disabled. 

We also agree with the FCC that ongoing participation by all stakeholders is critical as CER is developed and that there be transparency in every step of the process, allowing enough time for public consideration and comment, from research design to its implementation and finally its dissemination.

We hope that the FCC and IOM continue to see the importance of CER in providing information to patients and providers, as well as the risks associated with using cost analysis associated with CER for treatment decisions.

Comparative effectiveness research is not about dictating what kind of care should be provided, it's about providing patients and doctors with the information they need to make the best medical decisions.

PIPC is encouraged with the ongoing efforts of Sens. Max Baucus (D-MT) and Kent Conrad (D-ND) and Rep. Kurt Schrader (D-OR) who have authored strong, patient-centered CER bills (S. 1213 and H.R. 2502) and we encourage lawmakers on both sides of the aisle to advance CER within their framework.

We look forward to working with Secretary Sibelius, the Federal Coordinating Council, other members of the Administration, and Members of Congress as they work through the legislative process.


About PIPC
The Partnership to Improve Patient Care was formed in November 2008 to support new comparative effectiveness research proposals that are centered on patient and provider needs; raise awareness about the value of well-designed CER; and promote the important role of continued medical innovation as part of the solution to cost and quality challenges in health care. Partnership members include a wide range of healthcare organizations representing patient, provider and industry advocacy groups.  

AttachmentSize
PIPC_FCC_IOM_Statement_07082009.pdf63.28 KB